Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of ABBV-668 in Subjects With Moderate to Severe Ulcerative Colitis

NCT05570006 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05570006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05570006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of ABBV-668 in Subjects With Moderate to Severe Ulcerative Colitis
Lead sponsor
AbbVie
Phase
Phase 2
Overall status
Completed
Start date
March 16, 2023
Completion date
December 23, 2024
Enrollment
30 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis